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INCREASED plasma histamine levels were associated with
significantly lowered diamine and type B monoamine
oxidase activities in platelet-rich plasma of atopic eczema
(AE) patients. The diamine oxidase has almost normal
cofactor levels (pyridoxal phosphate and Cu2+) but the
cofactor levels for type B monoamine oxidase (flavin
adenine dinucleotide and Fe2+) are lowered. The biogenic
amines putrescine, cadaverine, spermidine, spermine, tyr-
amine and serotonin in the sera, as well as dopamine and
epinephrine in EDTA-plasma were found to be normal.
It is unlikely, therefore, that these amines are responsible
for the decreased activities of monoamine and diamine
oxidase in these patients. The most likely causative factors
for the inhibition of the diamine oxidase are nicotine,
alcohol, food additives and other environmental chemi-
cals, or perhaps a genetic defect of the diamine oxidase.
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Introduction
Many attempts have been made to use the activity
of the mitochondrial B-type monoamine oxidase of
platelets for the diagnosis of mental disease.
1-3
However, the results remain contradictory.
3 All
attempts to use diamine oxidase for the diagnosis
of certain diseases have been unsuccessful until
now, owing to an uncertain discrimination between
the normal and pathological range. The preferred
substrates of type B monoamine oxidase are
benzylamine, 2-phenylethylamine, dopamine, tyr-
amine and, with lower activity, tryptamine.
>5
N-methylhistamine, histamine methylated by N-
methyl-transferase, is also oxidized by type B
monoamine oxidase. 6’7 This enzyme is therefore
important in catabolizing histamine. 6’7 Diamine
oxidase is active on short-chain aliphatic diamines,
such as putrescine and cadaverine, 8’9 and is also the
first and major histamine catabolizing enzyme. 8’9
The purpose of this study was to evaluate the
activity and the cofactor levels of the histamine
catabolizing enzymes, monoamine and diamine
oxidase, in platelets of atopic dermatitis patients and
healthy controls.
Materials and Methods
Twenty-one patients with clinically proved
atopic eczema (age 15-44 years) and 13 healthy
volunteers with no allergic history (age 1 .6-39 years)
gave their consent to participate. All patients
avoided any steroid or antihistaminic treatment for
at least 3 months before admission.
Platelet-rich plasma (PRP) was obtained by
centrifuging the stabilized (EDTA) blood at 53 g
(C) 1993 Rapid Communications of Oxford ktd
for 10 min at 20C. The oxidases were measured by
the method of K6chli and Wartburg
4 with minor
modifications. An aliquot (0.6 ml) of peroxidase
buffer (8.3 mg peroxidase in 100 ml 0.1 M sodium
phosphate, pH 7.15), 0.2 ml PRP and 10 tl 10%
Triton X-100 were mixed. After 5 min 0.2 ml of
0.25mM 2’,7’-dichloro-fluorescein diacetate dis-
solved in 0.01 N NaOH and 10/21 1 mM benzyl-
amine (for monoamine oxidase) or 10/21 50 mM
putrescine (for diamine oxidase) were added and
mixed. The absorbance at 502 nm was recorded at
15 to 25 min, at 20C, on a Shimadzu UV-160
spectrophotometer.
Histamine was measured in EDTA plasma by the
method of Shore
2 using a Perkin-Elmer LS-2 filter
fluorimeter. Serum copper,
13 serum pyridoxal
phosphate,
14 serum iron,s EDTA-blood haemoglo-
bin6 and flavin adenine dinucleotide (FAD) in
EDTA-blood17 were measured by routine proce-
dures as outlined.
After deproteinisation of the sera with sulfosali-
cylic acid, putrescine and cadaverine were isolated
from the supernatant by solid phase extraction.
Dansyl derivatives formed after dansyl chloride
treatment were extracted with ethyl acetate in the
eluted liquid. The organic phase was dried and the
residue solved in acetonitrile. Putrescine and
cadaverine concentrations were measured fluorome-
trically after their separation using a HPLC system
with gradient elution. 18’19 The system contained an
internal standard. Spermidine and spermine con-
centrations were measured in a similar way, but
without the solid phase extraction at the beginning
of the whole procedure. 8’19 Tyramine was isolated
from the sera by solid phase extraction on Bond
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Elut RP-C18 columns. It was measured after
separation using an HPLC system with elec-
trochemical detection.2’21 This system also con-
tained an internal standard. Serum serotonin was
separated from accompanying materials by HPLC
and measured fluorometrically.
22 Dopamine, epi-
nephrine and norepinephrine concentrations in
EDTA-plasma were determined by reverse phase
HPLC with electrochemical detection.
23
EDTA-blood samples were frozen twice and
thawed for the induction of haemolysis. The
haemolysate was diluted 1:3 with bi-distilled water.
The analysis of the biogenic amines was then
performed as described for the sera. 18’9
The blood samples for atopic eczema patients and
control persons were drawn at the same time of the
day, although a diurnal variation in the DAO/
MAO-B levels was not seen.
O-phthalaldehyde, histamine, benzylamine, put-
rescine, Triton X-100 were obtained from Sigma,
Miinchen, Germany; 2’,7’-dichlorofluorescein diace-
tate from Serva Heidelberg, Germany; and horse-
radish peroxidase from Boehringer-Mannheim,
Germany. Other chemicals were reagent grade
quality.
Results and Discussion
The investigations showed reduced type B
monoamine (MAO) and diamine oxidase (DAO)
activities in platelet-rich plasma of atopic eczema
patients when compared with control subjects
(Tables 1 and 2). The difference was highly
significant for the first step histamine catabolizing
enzyme, diamine oxidase, < 0.001) and signifi-
cant for the methyl histamine catabolizing enzyme
monoamine .oxidase B, (p < 0.05). Concomitantly
with reduction of monoamine and diamine oxidase
activities plasma histamine levels were increased
(Table 3). High plasma histamine levels in atopic
eczema have been reported in fasting subjects as
well as after food ingestion.24’2s Low monoamine
and diamine oxidase activities may account for
increased histamine levels of endogenous or
exogenous origin in atopic eczema patients.
The cofactor levels for monoamine oxidase,
flavin adenine dinucleotide (FAD) and iron, were
lowered in AE patients when compared with
control subjects (Table 1). Iron values were at the
bottom of the normal range. Despite the lowered
iron concentrations haemoglobin values were
almost normal (Table 1), suggesting that AE
patients may have a small iron storage deficiency.
FAD in these patients was significantly lowered
(p < 0.005) when compared with the control group
(Table 1). Monoamine oxidase activity can be
restored by iron and vitamin B2 supplementation.
The cofactor levels for diamine oxidase,
pyridoxal phosphate and copper,
26 were almost
normal in the atopic group (Table 2). It was
therefore concluded that, contrary to monoamine
oxidase activity, a reason other than the cofactor
deficiency must be responsible for the lowered
activity of diamine oxidase. Biogenic amines, food
additives, or drugs2v’28 are the most probable
candidates for inhibition of the activity. Drugs have
Table 1. Monoamine oxidase activity, cofactor level and haemoglobin concentration in atopic eczema
Type B monoamine
oxidase
(mmol/min/I)
FAD (/,g/I) Iron (/,g/dl) Haemoglobin (g/dl)
Atopic eczema 0.223 +_ 0.110 (19)
patients (n)
Controls (n) 0.371 +__ 0.085 (11
79.6 + 31.1 (16)
132 + 42 (11)
p < 0.005 Significance, p < 0.05
Student’s t-test
Generally accepted normal values.
men 94.6 _+ 25.8 (7) men 13.6 ___
1.5 (7)
women 73.6 _+ 27.0 (13) women 13.2 _+ 0.9 (13)
men 130 _+ 50* men 15.5 _+ 2.5*
women 110_+50 women 14_+2
NS NS
Table2. Diamine oxidase activity and cofactor level in atopic eczema patients and healthy
controls
Diamine oxidase Copper (/,g/dl)
(mmol/min/I)
Pyridoxal phosphate (/,g/I)
Atopic eczema 0.270 _+ 0.089 (18) 125.3 _+ 28.9 (18) 12.1 _+ 9.4 (17)
patients (n)
Controls (n) 0.511 _+ 0.125 115 _+ 50* 10.8 _+ 7.2 (11)
Significance, p < 0.001 NS NS
Student’s t-test
Generally accepted normal values.
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Table 3. Biogenic amine levels in sera and blood of atopic eczema patients and healthy controls
Putrescine Cadaverine Spermidine Spermine
(/g/I) (/g/I) (/g/I) (#g/I)
Tyramine Histamine (plasma)
(#g/I) (#g/I)
Sera
Atopic eczema 25.0 6.9 5.4 __+ 2.2 31.1 ___
8.3 4.6 __+ 2.9
patients (n 21
Controls (n 13) 22.8 + 6.0 4.9 + 1.3 35.2 + 14.2 6.0 + 4.6
Sign ificance, NS NS NS NS
Student’s t-test
Blood
Atopic eczema 95.4 + 35.5 18.7 + 14.3 2211 + 597 1349 _+ 410
patients (n 12)
Controls (n 13) 65.1 _+ 17.2 15.5 _+ 4.0 2150 _+ 644 1477 +_ 268
Significance, NS NS NS NS
Student’s t-test
1.4 _+ 0.7 6.28 _+ 1.42
1.4 + 1.0 2.25 + 1.00
NS p < 0.001
to be excluded as the reason for lowered DAO
activities, as the patients in our study were free of
any drug. However, in spite of normal pyridoxal
phosphate levels we found that decreased diamine
oxidase activity may be reversed by vitamin B6
supplementation.
11
The studies show that the sera of atopic eczema
patients have normal biogenic amine (putrescine,
cadaverine, spermidine, spermine and tyramine)
concentrations, when compared with control
individuals (Table 3). In atopic eczema the
dopamine (21.2 18.4 vs. control value 16.6 _+
13.7, NS),
23 epinephrine (36.4 17.5 vs. control
value 43.1 22.2, NS)
23 and serotonin (148 _+ 81
vs. control value 125 q- 75, NS) (unpublished)
concentrations are also normal. The only measured
biogenic amine with elevated concentration was
norepinephrine (401.3 q-164.5 vs. control value
174.3 q- 55.8, p < 0.005). The possible reasons for
the elevated norepinephrine values have been
discussed.2’29-1 In the same patients reduced
MAO-B and DAO activities in platelet-rich plasma
(Tables 1 and 2) are paralleled by concomitantly
increased histamine concentrations (Table 3) (see
also References 32 and 33). The type A and B
monoamine oxidases have only small differences in
their substrate specificity. Some of the preferred
substrates of type A monoamine oxidase are
dopamine, norepinephrine, epinephrine, tyramine
and serotonin. Type A monoamine oxidase activity
might also be lowered. Because of limitations in the
sensitivity of the method used for the measurements
it was not possible for this to be evaluated directly.
However, the biogenic amines described above
are not responsible for the low oxidase activities in
these patients, since their concentrations in the sera
were normal. Furthermore we found almost normal
cofactor levels for DAO but lowered cofactor
concentrations for MAO-B (see also Reference 33).
This means that the lowered MAO-B activities may
be explained by the lowered cofactor concentra-
tions, but this explanation does not hold for the
measured DAO values. The remaining candidates
for the inhibition of DAO are nicotine, alcohol,
food additives
27 or other environmental factors.
These powerful oxidase inhibitors can also induce a
release of histamine (pseudoallergic reaction). The
result is a further increase of histamine concentra-
tion and an oxidase overload.
Although nicotine or alcohol are able to inhibit
DAO activity, the general low activities of patients"
DAO in our study cannot be caused by these drugs,
because patients did not smoke or drink any more
alcohol during treatment than the control patients.
A short time overload of the oxidases with
concomitant competitive inhibition may also be
caused by food containing high amounts of
biogenic amines. Nevertheless allergic reactions are
also responsible for a rise of the histamine levels.
Although mercurials may induce changes in the
oxidase activities,
4 the blood mercurial concentra-
tions of our patients are identical to values
measured in the control persons (0.8 _--+-0.5 vs.
control value 1.2 0.9 #g/l, NS) and therefore not
responsible for the oxidase changes measured in
these patients.
Circulating immune complexes and IgE in the
patients’ blood activates the coagulation system
with elevation of platelet aggregation24’5 and
histamine release with further enhancement of the
aggregation36--a process probably related to the
DAO activities of platelets. A puzzling question
may then also be answered" why is the histamine
level in the patients’ sera elevated but not the level
of the other normally present biogenic amines? The
other biogenic amines are presumably catabolized
by the amine oxidases outside the platelets. Platelet
amine oxidases, essentially DAO, may then serve
especially to detoxify high histamine concentra-
tions. Human blood, with 140 to 440 platelets/nl,
is the major ’organ’ for metabolizing circulating
histamine. Most other biogenic amines are
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catabolized by MAO-A or MAO-Boxidases that
are present in sufficient amounts in, for instance,
nerve endings near their target cells.
It cannot be ruled out that a genetic defect
(including enzyme repression) may be responsible
for the present results. Further investigations
concerning platelet DAO inhibitory factors are in
progress in the authors’ laboratory.
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